3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
12
Thoracic
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
50
Lung Neoplasms
13
Neoplasms
8
Melanoma
6
Neoplasm Metastasis
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Ovarian Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Merkel Cell
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Large Cell
2
Carcinoma, Basal Cell
2
Brain Neoplasms
2
Advanced Non-Small Cell Lung Cancer
2
Adenocarcinoma
2
Vaccinia
1
Uterine Neoplasms
1
Interventions
pembrolizumab
4
Nivolumab
4
Ipilimumab
2
Interleukin-2
2
Drug Therapy
2
Biopsy
2
poly ICLC
1
pertuzumab
1
osimertinib
1
montanide ISA 51
1
liposomal doxorubicin
1
cobimetinib
1
cemiplimab
1
cc-486
1
brodalumab
1
atezolizumab
1
Trastuzumab
1
Tissue Banks
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Quality of Life
1
Psychiatric Rehabilitation
1
Poly I-C
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
cemiplimab
×
Thoracic
×
Clear all
NCT06171750
2026-03-06
ANCHOR
Ankyra Therapeutics, Inc
Phase 1
Recruiting
97 enrolled